Percutaneous ablation procedures for diseases of lung, prostate, kidney and bone

Series
Ablation methods
Status
Ongoing
Date
Number of report
022

Ask the expert

(we accept only company emails)

Different types of ablation methods are considered in the report, including radiofrequency ablation, cryoablation, microwave ablation. Thermal ablation is not considered.

Only percutaneous image-guided procedures are considered in the report. Endoscopic procedures are not considered.

The following conditions are considered:

  • Lung cancer
  • Prostate cancer
  • Kidney cancer
  • Tumors of long bones

Reimbursement is analyzed only for stand-alone ablation procedures. Combination of procedures is not considered.

The analysis is limited to the procedures with at least overnight hospital stay.

The report includes essential information about reimbursement and national funding, including:

  • Brief overview of reimbursement system for medical devices
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions in indications or scenarios for use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

  • Austria
  • Belgium
  • Denmark
  • England (UK)
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Sweden
  • Switzerland

Table of content is not available at the moment.

28

Jul 2017

The Ludwig Boltzmann Institute – Health Technology Assessment (LBI-HTA) has published results of systematic literature review of evidence in relation to efficacy and safety of radiofrequency ablation for patients with metastatic spinal lesions. In conclusion, LBI-HTA recommended radiofrequency ablation of spinal metastatic lesions for inclusion in benefit catalogue with restrictions.

Read more
(we accept only company emails)